Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis

Disease Markers

Volumn 24, Issue 1, 2008, Pages 33-39

  Assayag, Einor Ben ^a   Bova, Irena ^a   Kesler, Anat ^a   Berliner, Shlomo ^a   Shapira, Itzhak ^a   Bornstein, Natan M ^a,b  

^a TEL AVIV UNIVERSITY   (Israel)

^b TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

C reactive protein; Carotid atherosclerosis; Erythrocyte aggregation; Microinflammation

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN;

AGED; ARTICLE; ATHEROSCLEROSIS; CAROTID ARTERY OBSTRUCTION; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; ERYTHROCYTE AGGREGATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; IMAGE ANALYSIS; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR;

EID: 36448963453     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/184647     Document Type: Article

References (36)

1. A. Khera, J.A. de Lemos, R.M. Peshock, H.S. Lo, H.G. Stanek, S.A. Murphy, F.H. Wians Jr et al., Relationship between C-reactive protein and subclinical atherosclerosis: the Dallas Heart Study, Circulation 113(1) (3 Jan 2006), 38-43.
2. M. Miller, M. Zhan and S. Havas, High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey, Arch Intern Med 165(18) (10 Oct 2005), 2063-2068.
3. M. van Oijen, J.C. Witteman, A. Hofman, P.J. Koudstaal and M.M. Breteler, Fibrinogen is associated with an increased risk of Alzheimer disease and vascular dementia, Stroke 36(12) (2005), 2637-2641.
4. O. Rogowski, S. Toker, I. Shapira, S. Melamed, A. Shirom, D. Zeltser et al., Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals, Am J Cardiol 95(1) (1 Jan 2005), 152-155.
5. S. Berliner, O. Rogowski, S. Aharonov, T. Mardi, T. Tolshinsky, M. Rozenblat et al., Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease, Am Heart J 149(2) (Feb 2005), 260-267.
6. D. Zeltser, O. Rogowski, T. Mardi, D. Justo, T. Tolshinsky, Y. Goldin et al., Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein, Atherosclerosis 176(2) (Oct 2004), 297-301.
7. E.G. Grant, C.B. Benson, G.L. Moneta, A.V. Alexandrov, J.D. Baker, E.I. Bluth, B.A. Carroll, M. Eliasziw, J. Gocke, B.S. Hertzberg, S. Katarick, L. Needleman, J. Pellerito, J.F. Polak, K.S. Rholl, D.L. Wooster and E. Zierler, Society of Radiologists in Ultrasound. Carotid artery stenosis: grayscale and Doppler ultrasound diagnosis-Society of Radiologists in Ultrasound consensus conference, Ultrasound Q 19(4) (Dec 2003), 190-198.
8. International committee for standardization in hematology. Recommendation of measurement of erythrocyte sedimentation rate of human blood, Immunochemistry 2 (1965), 235-254.
9. A. Clauss, Gerinnungsphysiologische Schnellmethode zur Bestimmung des Fibrinogens, Acta Haematol Basel 17 (1957), 237-246.
10. N. Rifai, R.P. Tracy and P.M. Ridker, Clinical efficacy of an automated high-sensitivity C-reactive protein assay, Clin Chem 45 (1999), 2136-2141.
11. V. Schechner, I. Shapira, S. Berliner, D. Comanesther, T. Hershcovici, J. Orlin et al., Significant dominance of fibrinogen over immunoglobulins, C-reactive protein, cholesterol and triglycerides in maintaining increased red blood cell adhesiveness/aggregation: a model in hypercholaesterolemic patients, Eur J Clin Invest 33 (2003), 955-961.
12. R. Gamzu, R. Rotstein, R. Fusman, D. Zeltser, A.S. Berliner and M.J. Kupferminc, Increased erythrocyte adhesiveness and aggregation in peripheral venous blood of women with pregnancy-induced hypertension, Obstet Gyneco.l 98 (2001), 307-312.
13. S. Berliner, I. Shapira, O. Rogowski, N. Sadees, R. Rotstein, R. Fusman et al., Combined leukocyte and erythrocyte aggregation in the peripheral venous blood during sepsis. A clue to the presence of a commonly shared adhesive protein(s), Int J Clin Lab Res 30 (2000), 27-31.
14. Y. Sharshun, S. Brill, T. Mardi, D. Justo, M. Rozenblat, Y. Goldinn et al., Inflammation at a glance: erythrocyte adhesiveness/aggregation to reveal the presence of inflammation in individuals with atherothrombosis, Heart Dis 5 (2003), 182-183.
15. R. Rotstein, R. Fusman, D. Zeltser, I. Shapira, E. Shabtai, D. Avitzour et al., The picture of inflammation: a new concept that combines the white blood cell count and erythrocyte sedimentation rate into a new hematologic diagnostic modality, Acta Haematol 106(3) (2001), 106-114.
16. P.J. Goldschmidt-Clermont, M.A. Creager, D.W. Lorsordo, G.K. Lam, M. Wassef and V.J. Dzau, Atherosclerosis 2005: recent discoveries and novel hypotheses, Circulation 112(21) (22 Nov 2005), 3348-3353.
17. M.P. de Maat, E.M. Bladbjerg, T. Drivsholm, K. Borch-Johnsen, L. Moller and J. Jespersen, Inflammation, thrombosis and atherosclerosis: results of the Glostrup study, J Thromb Haemost 1 (2003), 950-957.
18. M.P. Reilly, M.L. Wolfe, A.R. Localio and D.J. Rader, C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA), Arterioscler Thromb Vasc Biol 23 (2003), 1851-1856.
19. R.F. Redberg, N. Rifai, L. Gee and P.M. Ridker, Lack of association of C-reactive protein and coronary calcium by electron beam computed tomography in postmenopausal women: implications for coronary artery disease screening, J Am Coll Cardiol 36 (2000), 39-43.
20. M.E. Hunt, P.G. O'Malley, M.N. Vernalis, I.M. Feuerstein and A.J. Taylor, C-reactive protein is not associated with the presence or extent of calcified subclinical atherosclerosis, Am Heart J 141 (2001), 206-210.
21. T.J. Wang, M.G. Larson, D. Levy, E.J. Benjamin, M.J. Kupka, W.J. Manning et al., C-reactive protein is associated with subclinical epicardial coronary calcification in men and women: the Framingham Heart Study, Circulation 106 (2002), 1189-1191.
22. S. Hee Choi, H. Chang Kim, C. Woo Ahn, H. Keun Cho, B. Soo Cha, Y.S. Chung et al., Is high-sensitivity C-reactive protein associated with carotid atherosclerosis in healthy Koreans? Eur J Cardiovasc Prev Rehabil 12(6) (Dec 2005), 548-554.
23. S. Kiechl, G. Egger, M. Mayr, C.J. Wiedermann, E. Bonora, F. Oberhollenzer et al., Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study, Circulation 103 (2001), 1064-1070.
24. R. Blackburn, P. Giral, E. Bruckert, J.M. Andre, S. Gonbert, M. Bernard, M.J. Chapman and G. Turpin, Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects, Arterioscler Thromb Vasc Biol 21(12) (Dec 2001), 1962-1968.
25. S. Makita, M. Nakamura and K. Hiramori, The association of C-reactive protein levels with carotid intima-media complex thickness and plaque formation in the general population, Stroke 36(10) (Oct 2005), 2138-2142.
26. T.J. Wang, B.H. Nam, P.W. Wilson, P.A. Wolf, D. Levy, J.F. Polak, R.B. D'Agostino and C.J. O'Donnell, Association of C-reactive protein with carotid atherosclerosis in men and women: the Framingham Heart Study, Arterioscler Thromb Vasc Biol 22(10) (1 Oct 2002), 1662-1667.
27. A. Khera, D.K. McGuire, S.A. Murphy, H.G. Stanek, S.R. Das, W. Vongpatanasin, F.H. Wians Jr, S.M. Grundy and J.A. de Lemos, Race and gender differences in C-reactive protein levels, J Am Coll Cardiol 46(3) (2 Aug 2005), 464-469.
28. O. Rogowski, D. Zeltser, I. Shapira, M. Burke, V. Zakut, T. Mardi, E. Ben-Assayag, J. Serov, M. Rozenblat and S. Berliner, Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones, Biomarkers 9(1) (Jan-Feb 2004), 85-92.
29. E.B. Assayag, N.M. ornstein, I. Shapira, T. Mardi, Y. Goldin, T. Tolshinsky et al., Inflammation sensitive proteins and erythrocyte aggregation atherothrombosis, Int J Cardiol 98 (2005), 271-276.
30. S. Berliner, R. Ben-Ami, D. Samocha-Bonet, S. Abu-Abeid, V. Schechner, Y. Beigel et al., The degree of red blood cell aggregation on peripheral blood glass slides corresponds to inter-erythrocyte cohesive forces in laminar flow, Thromb Res 114 (2004), 37-44.
31. D. Zeltser, N.M. Bornstein, R. Rotstein, I. Shapira and S. Berliner, The erythrocyte adhesiveness/aggregation test in the peripheral blood of patients with ischemic brain events, Acta Neurol Scand 103 (2001), 316-319.
32. D. Zeltser, R. Rotstein, O. Rogowski, R. Fusman, I. Shapira, V. Prochorov et al., The erythrocyte adhesiveness/aggregation (EAAT) in the peripheral blood of patients with ischemic heart and brain disease with normal fibrinogen concentrations, Appl Rheol 10 (2000), 231-237.
33. T. Mardi, F. Aviv, R. Rotstein, R. Fusman, A. Roth, G. Keren et al., Detection of thrombolysis-related reduction in red blood cell adhesiveness/aggregation by using a simple slide test, Cardiology 97 (2002), 226-229.
34. J. Danesh, S. Lewington, S.G. Thompson et al., Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis, JAMA 294(14) (12 Oct 2005), 1799-809.
35. M. Fisher and H.J. Meiselman, Hemorheological factors in cerebral ischemia, Stroke 22(9) (Sep 1991), 1164-1169.
36. S.S. Daskalopoulou, M.E. Daskalopoulos, D. Perrea, A.N. Nicolaides and C.D. Liapis, Carotid artery atherosclerosis: what is the evidence for drug action? Curr Pharm Des 13(11) (2007), 1141-1159.